Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Evaluating night splinting after needle fasciotomy for Dupuytren's contracture

Official title: Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture - a Randomised Controlled Multicenter Trial

Run by Uppsala University · NCT05300893 · Data updated 2026-11-12

This study is testing if wearing a night splint after a needle procedure for Dupuytren's contracture can help prevent the condition from coming back compared to just physical therapy alone.

More Dupuytren Contracture trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment154 (estimated)
SponsorUppsala University
Academic / other
Locations3 sites (Falun, Dalarna County and 2 other locations)
StatusRecruiting
StartedSeptember 14, 2022
Main results expectedJanuary 2026
Study endsJanuary 2027
Registry record updatedMay 31, 2024
Trial IDNCT05300893 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with specific Dupuytren's contracture characteristics as defined by the Tubiana classification.

Probably not a fit

Patients with advanced Dupuytren's contracture or those who have previously undergone treatment for the same digit may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of night splinting following percutaneous needle fasciotomy (PNF) in patients with Dupuytren's contracture. Patients will be randomized into two groups: one receiving standard physical therapy and night splinting, and the other receiving physical therapy without splinting. The primary goal is to determine if night splinting reduces the recurrence rate of Dupuytren's contracture after PNF. This approach aims to provide insights into optimizing post-treatment care for this condition.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies that reduce the recurrence of Dupuytren's contracture after treatment.

How similar studies have gone: While the effectiveness of night splinting is debated, this study aims to provide new insights, as similar approaches have not been extensively validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years of age and older,
* Palpable Dupuytren strand with passive extension deficit according to stadium 1 and 2 of the classification of Tubiana in one or two fingers excluding the thumb, defined as at least 30 degrees in the MCP joint and/or at least 20 degrees in the PIP joint and a maximum of 75 degrees in the MCP or PIP joint

Exclusion Criteria:

* Multiple, invasive or wide strands in the palm,
* Skin irritation,
* Strand localization in the digit only,
* Digital nerve injury,
* Any former treatment for Dupuytren's contracture in the same digit,
* Thumb contracture,
* Stadium 3 and 4 according to the classification of Tubiana

Where it's running

  • Falu Lasarett
    Falun, Dalarna County, Sweden
    Recruiting
  • Akademiska Sjukhuset
    Uppsala, Uppsala County, Sweden
    Recruiting
  • Universitetssjukhuset Örebro
    Örebro, Örebro County, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.